ProShare Advisors’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-31,299
| Closed | -$129K | – | 2267 |
|
|
2022
Q1 | $129K | Sell |
31,299
-5,169
| -14% | -$18.8K | ﹤0.01% | 1986 |
|
|
2021
Q4 | $130K | Buy |
36,468
+15,075
| +70% | +$52.7K | ﹤0.01% | 2159 |
|
|
2021
Q3 | $78K | Sell |
21,393
-21,912
| -51% | -$88.6K | ﹤0.01% | 1940 |
|
|
2021
Q2 | $189K | Sell |
43,305
-617
| -1% | -$2.51K | ﹤0.01% | 2160 |
|
|
2021
Q1 | $181K | Buy |
43,922
+7,514
| +21% | +$32.6K | ﹤0.01% | 2065 |
|
|
2020
Q4 | $145K | Buy |
36,408
+16,263
| +81% | +$52.6K | ﹤0.01% | 1928 |
|
|
2020
Q3 | $54K | Sell |
20,145
-2,192
| -10% | -$6.07K | ﹤0.01% | 1588 |
|
|
2020
Q2 | $61K | Buy |
+22,337
| New | +$62.3K | ﹤0.01% | 1623 |
|
|
2020
Q1 | – | Sell |
-21,926
| Closed | -$103K | – | 1696 |
|
|
2019
Q4 | $103K | Buy |
21,926
+3,502
| +19% | +$14.3K | ﹤0.01% | 1692 |
|
|
2019
Q3 | $62K | Buy |
18,424
+3,129
| +20% | +$10.3K | ﹤0.01% | 1588 |
|
|
2019
Q2 | $50K | Sell |
15,295
-402
| -3% | -$1.16K | ﹤0.01% | 1574 |
|
|
2019
Q1 | $48K | Buy |
15,697
+488
| +3% | +$1.58K | ﹤0.01% | 1616 |
|
|
2018
Q4 | $41K | Sell |
15,209
-2,452
| -14% | -$8.08K | ﹤0.01% | 1532 |
|
|
2018
Q3 | $59K | Sell |
17,661
-1,356
| -7% | -$4.19K | ﹤0.01% | 1714 |
|
|
2018
Q2 | $49K | Buy |
19,017
+650
| +4% | +$1.62K | ﹤0.01% | 1752 |
|
|
2018
Q1 | $40K | Sell |
18,367
-2,965
| -14% | -$6.67K | ﹤0.01% | 1685 |
|
|
2017
Q4 | $42K | Buy |
+21,332
| New | +$46.4K | ﹤0.01% | 1776 |
|
|
2017
Q3 | – | Sell |
-12,695
| Closed | -$41K | – | 1414 |
|
|
2017
Q2 | $41K | Buy |
+12,695
| New | +$36K | ﹤0.01% | 1422 |
|
|
2016
Q2 | – | Sell |
-18,943
| Closed | -$16K | – | 1623 |
|
|
2016
Q1 | $16K | Sell |
18,943
-3,584
| -16% | -$3.47K | ﹤0.01% | 1578 |
|
|
2015
Q4 | $27K | Buy |
22,527
+7,776
| +53% | +$10.8K | ﹤0.01% | 1699 |
|
|
2015
Q3 | $25K | Sell |
14,751
-4,778
| -24% | -$9.37K | ﹤0.01% | 1426 |
|
|
2015
Q2 | $41K | Sell |
19,529
-3,026
| -13% | -$7.34K | ﹤0.01% | 1615 |
|
|
2015
Q1 | $61K | Sell |
22,555
-2,513
| -10% | -$6.38K | ﹤0.01% | 1849 |
|
|
2014
Q4 | $64K | Sell |
25,068
-21,304
| -46% | -$47.9K | ﹤0.01% | 1896 |
|
|
2014
Q3 | $85K | Sell |
46,372
-10,517
| -18% | -$22.9K | ﹤0.01% | 2198 |
|
|
2014
Q2 | $152K | Sell |
56,889
-57,260
| -50% | -$172K | ﹤0.01% | 2266 |
|
|
2014
Q1 | $400K | Buy |
+114,149
| New | +$506K | 0.01% | 2037 |
|
|
2013
Q4 | – | Sell |
-71,209
| Closed | -$289K | – | 2003 |
|
|
2013
Q3 | $289K | Buy |
71,209
+1,580
| +2% | +$6.9K | 0.01% | 1924 |
|
|
2013
Q2 | $290K | Buy |
+69,629
| New | +$269K | 0.01% | 1760 |
|
Other funds holding ATRS
ProShare Advisors's ATRS Position: Q2 2022 in Review
ProShare Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 31,299 shares — an estimated $129K sold.
ProShare Advisors first reported a position in ATRS in Q2 2013 and held it in 29 quarters. The position peaked at $400K in Q1 2014. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- ProShare Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- ProShare Advisors sold 31,299 Antares Pharma, Inc. shares in Q2 2022, an estimated $129K.
- ProShare Advisors first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 29 quarters.
- ProShare Advisors's Antares Pharma, Inc. position peaked at $400K in Q1 2014.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.